- In January 2025, Olympus Latin America acquired Sur Medical SpA’s distribution business in Chile, establishing Olympus Corporation Chile. This acquisition enables direct access to Chile’s growing healthcare market, streamlining the distribution of Olympus products and enhancing customer service and support in the region
- In November 2024, Merit Medical Systems has completed the acquisition of Cook Medical’s lead management portfolio for approximately USD 210 million. This acquisition enhances Merit’s electrophysiology and cardiac rhythm management business by adding a comprehensive range of devices used in lead removal and replacement procedures for pacemakers and implantable cardioverter-defibrillators. The integration of these products strengthens Merit’s position in the inflation device market
- In May 2024, Merit Medical Systems announced the U.S. commercial release of the basixSKY inflation device. This analog device is designed for endovascular interventions like balloon angioplasty and stent placement. It features a comfort-grip handle for one-handed preparation and minimizes rotational torque and handle revolutions to reach pressure. The device is available as a standalone solution and in kits with Merit Angioplasty Packs, configured to offer complementing AccessPLUS, Honor, and PhD hemostasis valves
- In January 2022, Medtronic has acquired Affera, a cardiac technology company specializing in mapping, navigation, and ablation systems for treating arrhythmias like atrial fibrillation. The acquisition marks Medtronic's entry into the cardiac mapping segment, expanding its cardiac ablation portfolio
- In April 2024, Integra LifeSciences Corporation has completed the acquisition of Acclarent, Inc., a company specializing in ENT (ear, nose, and throat) solutions. This acquisition enhances Integra's portfolio in the ENT market, expanding its capabilities in innovative medical technologies for sinus, ear, and nasal treatments, driving further growth in the healthcare sector
Frequently Asked Questions
The major factors driving the growth of the Europe inflation device market are rising case of cardiovascular diseases, wide range of applications of inflation devices, increasing number of minimally invasive surgeries and aging population and chronic disease burden.
Key trends in the Europe inflation device market include integration of precision medicine, minimally invasive techniques, and smart surgical tools.
Challenges in the Europe inflation device market include low-cost alternatives of inflation devices and shortage of healthcare professionals limiting device utilization.
